期 |
标题 |
文件 |
卷 94, 编号 9 (2022) |
Mechanical circulatory support in refractory cardiogenic shock: retrospective register study |
 (Rus)
|
Savvinova P., Manchurov V., Haes B., Skrypnik D., Vasilieva E., Shpektor A.
|
卷 94, 编号 9 (2022) |
Impact of anxiety disorders on adherence to anticoagulant therapy in patients with atrial fibrillation |
 (Rus)
|
Fomicheva A., Troshina D., Simonov A., Kopylov P., Andreev D., Volel B.
|
卷 94, 编号 9 (2022) |
The effectiveness of cardiac contractility modulation in patients with chronic heart failure and atrial fibrillation: results of the 12-month follow-up |
 (Rus)
|
Safiullina A., Uskach T., Sapelnikov O., Grishin I., Cherkashin D., Amanatova V., Akchurin R., Tereshchenko S.
|
卷 94, 编号 9 (2022) |
Ectopic obesity in patients without manifested cardiovascular disease: regulations, frequency and clinical characteristics |
 (Rus)
|
Podzolkov V., Bragina A., Osadchiy K., Rodionova Y., Djafarova Z., Khalenyan M., Dishkaya S.
|
卷 94, 编号 9 (2022) |
Features of vectorcardiograms in patients with hypertension complicated by chronic heart failure with reduced left ventricle ejection fraction |
 (Rus)
|
Sakhnova T., Blinova E., Yurasova E., Uskach T., Blinova N., Aidu E., Trunov V., Saidova M.
|
卷 94, 编号 9 (2022) |
Remote electrocardiogram telemonitoring after endovascular interventions on the coronary arteries |
 (Rus)
|
Danilushkin Y., Basinkevich A., Shamrina N., Bubnov D., Silvestrova G., Ageev F., Matchin Y.
|
卷 94, 编号 9 (2022) |
The atorvastatin effects on the prevention of contrast-induced acute kidney injury during computed tomography with contrast media |
 (Rus)
|
Vasin A., Mironova O., Fomin V.
|
卷 94, 编号 8 (2022) |
Esophagoprotective therapy in patients with erosive esophagitis |
 (Rus)
|
Bakulina N., Tikhonov S., Topalova Y., Ilchishina T., Vasiliev R.
|
卷 94, 编号 8 (2022) |
Comparative evaluation of the effectiveness of narlaprevir in the composition of interferon and interferon-free treatment regimens for patients with chronic hepatitis C |
 (Rus)
|
Grushko I., Romanova E., Tverdokhlebova T., Gapon M., Vodyanitskaya S.
|
卷 94, 编号 8 (2022) |
Modification of dietary patterns in patients with non-alcoholic steatohepatitis |
 (Rus)
|
Sasunova A., Goncharov A., Morozov S., Isakov V.
|
卷 94, 编号 8 (2022) |
Composition of oropharyngeal microbiota in patients with COVID-19 of different pneumonia severity |
 (Rus)
|
Starikova E., Galeeva J., Andreev D., Sokolov P., Fedorov D., Manolov A., Pavlenko A., Klimina K., Veselovsky V., Zaborovsky A., Evdokimov V., Andreev N., Devkota M., Fomenko A., Khar'kovskii V., Asadulin P., Kucher S., Cheremushkina A., Yanushevich O., Maev I., Krikheli N., Levchenko O., Ilina E., Govorun V.
|
卷 94, 编号 8 (2022) |
The study of microcirculation and tissue metabolism as early diagnostic criteria for the risk of diabetic foot development |
 (Rus)
|
Mkrtumyan A., Zvenigorodskaya L., Shinkin M.
|
卷 94, 编号 7 (2022) |
Peculiarities of hemostasis in patients with COVID-19 |
 (Rus)
|
Kalinskaya A., Dukhin O., Molodtsov I., Anisimova A., Sokorev D., Elizarova A., Sapozhnikova O., Glebova K., Shakhidzhanov S., Spiridonov I., Ataullakhanov F., Shpektor A., Vasilieva E.
|
卷 94, 编号 7 (2022) |
New opportunities for preventive anti-inflammatory therapy in the management of patients with moderate and severe COVID-19 |
 (Rus)
|
Gorelov A., Kalyuzhin O., Bagaeva M.
|
卷 94, 编号 7 (2022) |
Data from the Russian Severe Asthma Registry (RSAR) |
 (Rus)
|
Belevskiy A., Nenasheva N., Kravchenko N., Makar'iants N., Kuntsev D.
|
卷 94, 编号 7 (2022) |
Pregnancy in paroxysmal nocturnal hemoglobinuria: from survival to life |
 (Rus)
|
Vinogradova M., Kulagin A., Shmakov R.
|
卷 94, 编号 7 (2022) |
Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation |
 (Rus)
|
Zyryanov S., Dyakov I., Aisanov Z.
|
卷 94, 编号 7 (2022) |
Prevalence and clinical associations of iron deficiency in patients with decompensated heart failure, depending on the diagnostic criteria used for iron deficiency |
 (Rus)
|
Kobalava Z., Lapshin A., Tolkacheva V., Galochkin S.
|
卷 94, 编号 7 (2022) |
Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia |
 (Rus)
|
Chelysheva E., Petrova A., Shukhov O., Bykova A., Nemchenko I., Gurianova M., Tsyba N., Turkina A.
|
卷 94, 编号 7 (2022) |
Multiple myeloma: response to treatment and survival of patients according to the interim analysis of the Russian observational, retrospective-prospective, multicenter cohort study (MULTISPECT) |
 (Rus)
|
Ptushkin V., Kunst M., Mitina T., Konstantinova T., Rachkova N., Shelekhova T., Elykomov I., Kuchma G., Farizova K., Vinogradova O., Nikitin E., Pashanov E.
|
卷 94, 编号 7 (2022) |
Нospital outcomes of coronary artery bypass grafting in patients with coronary heart disease with previous percutaneous coronary intervention |
 (Rus)
|
Kremneva L., Suplotov S., Abaturova O., Stognii N., Shalaev S.
|
卷 94, 编号 7 (2022) |
Combined use of the GRACE ACS risk score and comorbidity indices to increase the effectiveness of hospital mortality risk assessment in patients with acute coronary syndrome |
 (Rus)
|
Zykov M., Dyachenko N., Velieva R., Kashtalap V., Barbarash O.
|
卷 94, 编号 7 (2022) |
Chronic kidney disease in outpatients with arterial hypertension: clinical characteristics and treatment efficacy (according to the national registry) |
 (Rus)
|
Oschepkova E., Aksenova A., Orlovsky A., Chazova I.
|
卷 94, 编号 7 (2022) |
Biochemical markers of thrombotic complications in the acute period of ischemic stroke |
 (Rus)
|
Kochetov A., Lyang O., Zhirova I., Ivoylov O.
|
卷 94, 编号 7 (2022) |
Seх differences in treatment of acute coronary syndrome patients. Data from federal registry of acute coronary syndrome 2016–2019 |
 (Rus)
|
Sagaydak O., Oschepkova E., Chazova I.
|
卷 94, 编号 6 (2022) |
Impact of kidney biopsy on the management of patients in the rheumatology department: retrospective study |
 (Rus)
|
Kokhanchuk V., Skvortsov A., Shchegoleva E., Kuznetsova E., Novikov P., Stoliarevich E., Varshavsky V., Moiseev S., Bulanov N.
|
卷 94, 编号 6 (2022) |
Soy protein as part of a low-protein diet is a new direction in cardio- and nephroprotection in patients with 3B–4 stages of chronic kidney disease: prospective, randomized, controlled clinical study |
 (Rus)
|
Milovanova L., Taranova M., Volkov A., Milovanova S., Beketov V.
|
卷 94, 编号 6 (2022) |
New opportunities for neuroprotective therapy of patients in the acute and early recovery period of ischemic stroke |
 (Rus)
|
Tanashyan M., Raskurazhev A., Zaslavskaya K., Kuznetsova P., Merkulova I.
|
卷 94, 编号 6 (2022) |
Risk factors of kidney injury in patients with COVID-19 |
 (Rus)
|
Shchepalina A., Chebotareva N., Kitbalian A., Potapov P., Nartova A., Akulkina L., Brovko M., Sholomova V., Moiseev S.
|
卷 94, 编号 6 (2022) |
Evaluation of hemostasis disorders using the thrombodynamic test in patients with chronic glomerulonephritis with nephrotic syndrome |
 (Rus)
|
Berns A., Sovetnikov E., Chebotareva N., Berns S., Solonkina A., Guliaev S., Kraeva V., Moiseev S.
|
卷 94, 编号 6 (2022) |
Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5 |
 (Rus)
|
Dzgoeva F., Remizov O., Botcieva V., Goloeva V., Malakhova N., Ikoeva Z.
|
卷 94, 编号 6 (2022) |
Urinary biomarkers of kidney injury in patients treated with anti-VEGF drugs |
 (Rus)
|
Grechukhina K., Chebotareva N., Zhukova L., Androsova T., Karpov V., Krasnova T.
|
卷 94, 编号 6 (2022) |
Remissions and progression of C3 glomerulopathy |
 (Rus)
|
Karunnaya A., Dobronravov V.
|
卷 94, 编号 5 (2022) |
Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit |
 (Rus)
|
Markina U., Fomina D., Lebedkina M., Kruglova T., Chernov A., Zagrebneva A., Mutovina Z., Karaulov A., Alexeeva E., Lysenko M.
|
卷 94, 编号 5 (2022) |
Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients’ treatment |
 (Rus)
|
Khripun A., Starshinin A., Antipova Y., Lysenko M., Urozhaeva Y., Gavrilenko O., Rusantsova N., Tyazhelnikov A., Tikhonovskaya E., Okolot N., Sokolova M., Fomina D., Simonova E., Kruglova T., Chernov A., Zagrebneva A.
|
卷 94, 编号 5 (2022) |
Difficult-to-treat rheumatoid arthritis in real clinical practice. Preliminary results |
 (Rus)
|
Galushko E., Gordeev A., Matyanova E., Olyunin Y., Nasonov E.
|
卷 94, 编号 5 (2022) |
Phenotypes of body composition, physical performance and quality of life in women with rheumatoid arthritis |
 (Rus)
|
Dobrovolskaya O., Toroptsova N., Feklistov A., Demin N., Sorokina A., Nikitinskaya O.
|
卷 94, 编号 5 (2022) |
Activity of ankylosing spondylitis in women within one year after childbirth |
 (Rus)
|
Krichevskaya O., Dubinina T., Ilinykh E., Glukhova S., Demina A., Andrianova I.
|
卷 94, 编号 5 (2022) |
Achievement of clinical-laboratory and ASAS-partial remission in patients with early axial spondyloarthritis according to the ESAC cohort at the 3rd year of follow-up |
 (Rus)
|
Timokhina D., Dubinina T., Demina A., Krichevskaya O., Erdes S.
|
卷 94, 编号 5 (2022) |
Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugs |
 (Rus)
|
Korolev M., Letyagina E., Sizikov A., Bogoderova L., Ubshaeva Y., Omelchenko V., Akimova A., Mullagaliev A., Chumasova O., Kurochkina Y.
|
卷 94, 编号 5 (2022) |
Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome |
 (Rus)
|
Reshetnyak T., Cheldieva F., Cherkasova M., Lila A., Nasonov E.
|
卷 94, 编号 5 (2022) |
The burden of progression of psoriatic arthritis. All-Russian register data |
 (Rus)
|
Korsakova Y., Loginova E., Korotaeva T., Gubar E., Glukhova S., Vasilenko E., Nasonov E.
|
卷 94, 编号 5 (2022) |
Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis |
 (Rus)
|
Abramkin A., Lisitsyna T., Veltishchev D., Seravina O., Kovalevskaya O., Glukhova S., Nasonov E.
|
卷 94, 编号 5 (2022) |
Evaluation of the association of polymorphisms of the CYP2C8 gene with the efficacy and safety of ketorolac in patients with postoperative pain syndrome |
 (Rus)
|
Muradian A., Sychev D., Blagovestnov D., Petrov D., Skukin D., Epifanova I., Sozaeva Z., Kachanova A., Denisenko N., Abdullaev S., Grishina E.
|
卷 94, 编号 4 (2022) |
Myocardial scintigraphy with 99mTc-pyrophosphate in the diagnosis of cardiac amyloidosis: place in the diagnostic algorithm, features of the implementation and interpretation of the study |
 (Rus)
|
Ansheles A., Nasonova S., Zhirov I., Saidova M., Stukalova O., Tereshchenko S., Sergienko V.
|
卷 94, 编号 4 (2022) |
Problems and opportunities to improve diagnosis of asthma and chronic obstructive pulmonary disease in Russia: resolution of advisory board |
 (Rus)
|
Avdeev S., Emelyanov A., Aisanov Z., Sinopalnikov A., Fomina D., Nenasheva N., Leshchenko I., Zaikova-Khelimskaia I., Vizel A., Demko I., Shaporova N., Shulzhenko L., Shabanov E.
|
卷 94, 编号 4 (2022) |
The possibilities of improving the treatment of chronic heart failure according to the results of a multicenter observational study BYHEART |
 (Rus)
|
Tereshchenko S., Cheremisina I., Safiullina A.
|
卷 94, 编号 4 (2022) |
Zonulin and I-FABP are markers of enterocyte damage in celiac disease |
 (Rus)
|
Bykova S., Sabelnikova E., Novikov A., Baulo E., Khomeriki S., Parfenov A.
|
卷 94, 编号 4 (2022) |
Predictive value of QRS complex duration in patients with chronic heart failure and atrial fibrillation: retrospective study |
 (Rus)
|
Uskach T., Sharapova Y., Safiullina A., Zinovyeva E., Tereshchenko S.
|
卷 94, 编号 4 (2022) |
Organizing pneumonia as a pulmonary manifestation of post-COVID syndrome: features of diagnosis and treatment |
 (Rus)
|
Akulkina L., Shchepalina A., Kitbalian A., Potapov P., Moiseev A., Brovko M., Sholomova V., Moiseev S.
|
251 - 300 的 548 信息 |
<< < 1 2 3 4 5 6 7 8 9 10 11 > >>
|